(Bloomberg)—China’s state-owned medical products maker is collecting plasma from the blood of people who have recovered from the novel coronavirus after discovering it helped critically ill patients.
China National Biotec Group Co. has been using this plasma, which contains highly potent antibodies, to treat more than 10 seriously ill patients since Feb. 8, the company said in an statement on its official WeChat account Thursday night. It claimed that those receiving the treatment improved within 24 hours, with reduced inflammation and viral loads along with better oxygen levels in the blood.
Drugmakers and the Chinese authorities are racing to develop a cure for the contagion that has so far killed more than 1,300 people, infected over 63,000 and has no approved treatment or vaccine. China has also unleashed a flurry of clinical trials — as many as 77 have been registered — in a bid to curb the outbreak that’s threatening its economic growth. Video Player is loading. Current Time 0:00
Stream Type LIVERemaining Time -0:001x Chapters descriptions off, selected captions settings, opens captions settings dialog captions off, selected This is a modal window. An unanticipated problem was encountered, check back soon and try again Error Code: MEDIA_ERR_UNKNOWN Session ID: 2020-02-14:daaf8972cbb9754b9e62d51e Player Element ID: brightcove-4581051Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteTransparencyOpaqueBackgroundColorBlackTransparencyOpaqueWindowColorBlackTransparencyTransparentFont Size50%Text Edge StyleNoneFont FamilyProportional Sans-SerifEnd of dialog window.This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.This is a modal window. This modal can be […]